About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Dallas | 283 Studies

Clinical Trials Prostate CancerDallas

Prostate Cancer Clinical Trials in Dallas

Find 283 clinical trials for prostate cancer near Dallas, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 283 trials

UnknownR-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of RecurrenceRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00045123·Homewood, Alabama and 57 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

TerminatedChemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024167·Gainesville, Georgia and 39 others

CompletedSafety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyThis is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with…NCT00974311·Birmingham, Alabama and 248 others

CompletedSipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial, the stereotactic radiation to multiple metastatic sites is delivered not only to eradicate sites of…NCT01818986·Dallas, Texas

TerminatedSafety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCA phase 1 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of prostate specific membrane antigen half-life extended bispecific T-cell engager acapatamab…NCT03792841·Campbell, California and 29 others

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.NCT00033631·Long Beach, California and 85 others

CompletedA Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThe primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide…NCT02799745·Birmingham, Alabama and 53 others

TerminatedStudy of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsAt the time of study termination, NUV-422-02 was a first-in-human, open-label, Phase 1 dose escalation study designed to evaluate the safety and efficacy of NUV-422.NCT04541225·Tucson, Arizona and 11 others

CompletedPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyPROSTVAC-VF is an investigational cancer vaccine.NCT00078585·Homewood, Alabama and 46 others

CompletedSafety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous TherapiesThe purpose of this study is to determine the safety profile, including the maximum tolerated dose (MTD), of ATI-1123 a liposomal formulation of docetaxel, in the treatment of…NCT01041235·Dallas, Texas and 1 other

CompletedA Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerThe purpose of this study is to determine the benefit of enzalutamide versus placebo as assessed by overall survival and progression-free survival in patients with progressive…NCT01212991·Birmingham, Alabama and 268 others

CompletedPhase II Sunitinib Prog Met AIPCThe purpose of this research study is to find out what effects (good and bad) Sutent has on you and your prostate cancer.NCT00599313·Phoenix, Arizona and 44 others

CompletedStudy of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerThe primary objective of this study was to compare the two alternate primary endpoints of radiographic progression-free survival (rPFS) and overall survival (OS) in patients with…NCT03511664·Scottsdale, Arizona and 87 others

RecruitingAdjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical ProstatectomyThis is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.NCT02064673·Dallas, Texas

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

UnknownMulti-Institutional Registry for Prostate Cancer RadiosurgeryTo address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.NCT01226004·Birmingham, Alabama and 43 others

CompletedA Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)PSMA ADC 2301 is a Phase 2, open-label, study to assess the anti-tumor activity and tolerability of Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in two…NCT01695044·Birmingham, Alabama and 35 others

RecruitingA Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasA phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients with locally advanced or…NCT06999187·Denver, Colorado and 9 others

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

PreviousPage 5 of 15Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma